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Neuromuscular electrical stimulation (NMES) facilitates ambulatory function after paralysis by activating the muscles
of the lower extremities. The NMES-assisted stepping can either be triggered by a heel-switch (switch-trigger), or by
an electromyogram (EMG)-based gait event detector (EMG-trigger). The command sources—switch-trigger or
EMG-trigger—were presented to each group of six chronic (>6 months post-stroke) hemiplegic stroke survivors.
The switch-trigger group underwent transcutaneous NMES-assisted gait training for 1 h, five times a week for
2 weeks, where the stimulation of the tibialis anterior muscle of the paretic limb was triggered with a heel-switch
detecting heel-rise of the same limb. The EMG-trigger group underwent transcutaneous NMES-assisted gait training
of the same duration and frequency where the stimulation was triggered with surface EMG from medial
gastrocnemius (MG) of the paretic limb in conjunction with a heel-switch detecting heel-rise of the same limb.
During the baseline and post-intervention surface EMG assessment, a total of 10 s of surface EMG was recorded
from bilateral MG muscle while the subjects tried to stand steady on their toes. A nonlinear tool—recurrence
quantification analysis (RQA)—was used to analyze the surface EMG. The objective of this study was to find the
effect of NMES-assisted gait training with switch-trigger or EMG-trigger on two RQA parameters—the percentage of
recurrence (%Rec) and determinism (%Det), which were extracted from surface EMG during fatiguing contractions
of the paretic muscle. The experimental results showed that during fatiguing contractions, (1) %Rec and %Det have
a higher initial value for paretic muscle than the non-paretic muscle, (2) the rate of change in %Rec and %Det was
negative for the paretic muscle but positive for the non-paretic muscle, (3) the rate of change in %Rec and %Det
significantly increased from baseline for the paretic muscle after EMG-triggered NMES-assisted gait training.
Therefore, the study showed an improvement in paretic muscle function during a fatiguing task following gait
training with EMG-triggered NMES. This study also showed that RQA parameters—%Rec and %Det—were sensitive
to changes in paretic/non-paretic muscle properties due to gait training and can be used for non-invasive muscle
monitoring in stroke survivors undergoing rehabilitation.
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The World Health Organization defines stroke as “the
rapid development of clinical signs and symptoms of a
focal neurological disturbance lasting more than 24 h or
leading to death with no apparent cause other than vas-
cular origin” [1]. Worldwide, 15 million people suffer a
stroke every year, and stroke is the second leading cause
of disability after dementia. India-centered studies have
presented a prevalence rate of 27–34/100,000 in the
35–44 age group to 822–1116/100,000 in the 75+ age
group [2-4]. The prevalence of stroke in younger indivi-
duals is higher in India as compared with high-income
nations [5]. The burden of stroke on the quality of life is
much greater in this younger age group of stroke survi-
vors [5-7]. Moreover, stroke drastically affects the eco-
nomical productivity for that younger age-group adding
further to the overall disease burden [5] and therefore
early rehabilitation to alleviate disability has a special
significance in developing countries.
The disability due to poor ability to walk in stroke
patients is frequently caused by the “foot-drop” symptom
that prevents the patient from being able to raise the
foot during the swing phase of walking [8]. The foot
slaps down on the ground after heel-strike and the toe
drags during the swing phase. In addition to that the
patients often lack from push-off power due to weakness
in ankle plantarflexors (like, gastrocnemius muscle),
which not only reduces walking speed, but also reduce
ankle dorsiflexion angles during the early swing phase of
gait [9]. Goldberg et al. [10] have shown that the ankle
plantarflexors are important for knee flexion velocity
during push-off. This leads to insufficient foot clearance
that puts the patient at risk for stumbling and falling [9].
Consequently, impairment of walking has been men-
tioned most frequently (39–90%) as the most important
disabling condition in community-dwelling stroke survi-
vors and improving walking ability has been found to be
the best way to reduce dependency [11,12]. Almost 30%
of patients who survive stroke are affected by foot-drop,
where the ankle dorsiflexors (e.g., tibialis anterior
muscle) are functionally impaired [8,9].
Neuromuscular electrical stimulation (NMES)-based
orthosis has been shown to enhance walking abilities, in-
creasing gait speed while lowering effort and has only re-
cently developed into a therapeutic intervention for stroke
rehabilitation [8,13-22]. NMES involves electrical stimula-
tion of nerves and muscles with continuous short pulses
of electrical current [23]. Hausdorff and Ring [20] showed
that the number of falls reduced significantly in hemipare-
tic patients who used FES to correct foot-drop. Although
FES provides orthotic benefit but the neurophysiological
therapeutic benefit has not been investigated thoroughly.
Recently, different command modalities are available
where NMES-assisted stepping can either be triggeredwith a heel-switch (switch-trigger) or with an electromyo-
gram (EMG)-based gait event detector (EMG-trigger). Al-
though both the modalities provide similar orthotic
benefit [24,25] where they assist in lifting the foot to clear
the ground during stepping action but the relative long-
term therapeutic benefit of one modality over the other in
facilitating recovery of neurophysiological function has
not rigorously been shown. Preliminary research demon-
strated the feasibility of EMG control of NMES in partial
paralysis as well as its therapeutic benefits [26-31]. Dutta
et al. [31] have shown therapeutic benefits in terms of in-
cremental improvement in the classification of the gait
event using a constant EMG-based classifier while the
command muscle was undergoing NMES-assisted gait
training. However, capturing the neurophysiological thera-
peutic effects in terms of changes in the properties of the
surface EMG from paretic muscles will require more
advanced analysis with tools like recurrence quantification
analysis (RQA), which is the focus of the current study.
RQA is a technique for detecting changes in the states
of a dynamical systems that does not need any a priori
constraint on data size, stationarity, and statistical distri-
bution [32]. RQA parameters are very sensitive in
detecting changes in surface EMG due to fatigue [33].
Webber et al. [34] showed that small changes in surface
EMG can be detected by RQA where the parameter—%Det
reflects the deterministic attributes of the signal whereas
the parameter—%Rec reflects the recurrence of the signal.
RQA parameters have been validated as means for fatigue
assessment with potential advantages such as the higher
sensitivity to neurophysiological changes in the muscle sta-
tus [35]. Therefore, the objective of this study was to inves-
tigate the effects of NMES-assisted gait training with two
different command sources—switch-trigger or EMG-
trigger—on two RQA parameters—the percentage of recur-
rence (%Rec) and determinism (%Det), which were
extracted from the surface EMG during fatiguing contrac-
tions of the paretic muscle in 12 chronic stroke survivors.
Methods
Subjects
Ten male and two female hemiplegic chronic (>6 months
post-stroke) stroke survivors (age: 56–75 years) volun-
teered for this study. Informed consent was obtained from
all the subjects before their participation. The study was
approved by the Institutional Review Board of Max Super-
speciality Hospitals Saket, New Delhi, India. The clinical
inclusion and exclusion criteria are tabulated in Table 1,
which were evaluated by a consulting neurologist.
Experimental setup
Experimental setup and the signal flow are shown in the
top panel of Figure 1. Surface EMG signals were
Table 1 Inclusion and exclusion criteria for the clinical
study
Inclusion criteria Exclusion criteria
Age 21–80 years Brainstem stroke
>6 months from a first clinical non-
hemorrhagic or hemorrhagic stroke
Epilepsy
Medically stable Severely impaired cognition and
communication
Unilateral lower extremity hemi-
paresis
History of peroneal nerve injury
Able to ambulate 16 feet (5 m)
continuously with minimal
assistance or less, without the use
of an ankle foot orthosis (AFO)
History of Parkinson’s, spinal cord
injury, traumatic brain injury,
multiple sclerosis, uncontrolled
seizure disorder





Electrical stimulation of the paretic
ankle dorsiflexors produces ankle
dorsiflexion to neutral without pain
Edema of the paretic lower
extremity
Full voluntary dorsiflexion of the
contralateral ankle
Absent sensation of lower leg and
foot
Skin intact on hemiparetic lower
extremity
History of cardiac arrhythmias with
hemodynamic instability
Cardiac pacemaker or other
implanted electronic system
Botulinum toxin injections to any
lower extremity muscle in the last
3 months
Evidence of deep venous
thrombosis or thromboembolism
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Ag/AgCl electrodes with 2-cm inter-electrode distance
following the SENIAM guidelines [36]. The surface
EMG signals were amplified and low-pass filtered (anti-
aliasing, frequency cutoff = 1000 Hz) with custom-made
amplifier before being sampled at 2400 Hz by 16-bit data
acquisition system (NI USB-6215, National Instruments,
USA). The data acquisition system also sampled the
heel-switch signal to monitor heel-rise and heel-strike of
the paretic foot. The digital output of the data acquisi-
tion system activated a switching circuit (clamp) by a
trigger pulse that disconnected the EMG electrode
inputs from the amplifier and connected them to the
common ground electrode from heel-rise to heel-strike
when the stimulation was delivered. The gain of the
custom-made amplifier was set to prevent saturation at
the maximum muscle activity. The control signal for
triggering NMES—the linear envelope (LE)—was com-
puted after digitally band-pass filtering (5th order But-
terworth, 3 dB bandwidth = 10–500 Hz), then full-wave
rectification and then low-pass filtering (5th order But-
terworth, 3 dB frequency cutoff = 3 Hz) the sampled
EMG signal. Visual biofeedback of the control signal
was provided to the subject on a computer monitor(bottom panel of Figure 1) while the subjects learned to
trigger the stimulation with surface EMG from their par-
etic MG muscle.
After achieving proficiency in EMG-triggered FES, the
subjects in the EMG-triggered group (see the next sec-
tion) walked with single-channel transcutaneous NMES
device (ODFS Pace, Odstock, UK) which delivered elec-
trical stimulation using saline-soaked sponge electrodes
to activate tibialis anterior of the paretic leg during
swing-phase of the gait cycle. The stimulation and
recording electrodes were attached to a customized
sleeve as shown in Figure 2, which was worn by the sub-
ject during each visit for gait training.
NMES intervention
The subjects were randomly allocated to one of the two
groups: GROUP EMG-triggered or GROUP Switch-trig-
gered, as explained below.
Group EMG-triggered
In this group, the subjects received EMG-triggered
transcutaneous NMES-assisted gait training on treadmill
for 1 h, five times a week for 2 weeks. The NMES was
triggered at the heel-rise of the paretic side that was
detected with a heel-switch only if the LE of the MG
crossed 75% of the MVC during preceding double-
support (push-off ) phase of the gait. Before walking with
EMG-triggered transcutaneous NMES, the subjects were
trained to activate paretic MG muscle for push-off using
biofeedback of the LE control signal in order to trigger
the NMES device.
Group switch-triggered
In this group, the subjects received heel-switch-triggered
transcutaneous NMES-assisted gait training on treadmill
for 1 h, five times a week for 2 weeks. The NMES was
triggered at the heel-rise of the paretic side that was
detected with a heel-switch.
In both the groups, NMES produced muscle contrac-
tions that mimic normal voluntary ankle movement, lift-
ing the foot off the ground and improving gait, by
applying electrical pulses to the common peroneal nerve
through the skin surface. Stimulation electrodes were
placed over the nerve using a textile sleeve (Figure 2),
which were connected by leads to the NMES device
(ODFS Pace, Odstock, UK).
Baseline and post-intervention RQA
During the baseline and post-intervention surface EMG
assessment, subjects were asked to stand steady on their
toes for a total of 10 s with heel-rise of both their feet
while the surface EMG was recorded from fatiguing bilat-
eral MG muscles. The EMG signals were amplified and
low-pass filtered (anti-aliasing, frequency cutoff = 1000 Hz)
Figure 1 Top panel: Experimental setup for EMG-triggered NMES training. The signal flow is overlaid where the raw surface EMG was
collected from MG muscle, which was amplified and low-pass filtered (anti-aliasing, frequency cutoff = 1000 Hz) before being sampled at 2400 Hz
by 16-bit data acquisition system (NI USB-6215, National Instruments, USA) in a personal computer (PC). The LE was computed after digitally
band-pass filtering (5th order Butterworth, 3 dB bandwidth = 10–500 Hz), then full-wave rectification and the low-pass filtering (5th order
Butterworth, 3 dB frequency cutoff = 3 Hz) the sampled EMG signal. Visual biofeedback of the control signal (150 ms sliding window) was
provided to the subject on a computer monitor (bottom panel) while the subjects learned to trigger the stimulation by activating their paretic
MG muscle by exceeding a subject-specific threshold of 75% of their maximal voluntary contraction (MVC) in conjunction with heel-rise detected
by the heel-switch of the ODFS Pace (Odstock, UK) electrical stimulator. Bottom panel: EMG visual biofeedback for EMG-triggered NMES training.
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2400 Hz by 16-bit data acquisition system (NI USB-6215,
National Instruments, USA). Then the sampled EMG sig-
nals were digitally band-pass filtered (5th order Butter-
worth, 3 dB bandwidth = 10–500 Hz) and re-sampled at
1024 Hz to be stored for offline analysis. The data acquisi-
tion system also sampled bilateral heel-switch signals to
monitor heel-rise and heel-strike of both the feet.The RQA was conducted offline from 9 s of the sur-
face EMG signal (half seconds of leading and trailing
data were discarded) from paretic and non-paretic MG
to estimate the parameters—%Det and %Rec from adja-
cent non-overlapping epochs of 1 s (1,024 data points)
for each subject. The first step in RQA was embedding
procedure where vectors representing the states of the
system were extracted. The phase space was assumed to
Figure 2 Photo of the subject-specific textile compression
sleeve with the EMG recording electrodes and the electrical
stimulation electrodes.
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vectors were extracted from 1 s epoch of the surface
EMG signal (i.e., data = {s (1), s(2),. . ., s (1024)}) by lag-
ging the signal by an integer number of samples (d = 3
[35]) as shown below,
v 1ð Þ ¼ s 1ð Þ; s 1þ dð Þ; s 1þ 2 dð Þ; . . . ; s D 1ð Þ  dð Þf g
v 2ð Þ ¼ s 2ð Þ; s 2þ dð Þ; s 2þ 2 dð Þ; . . . ; s 1þ D 1ð Þ  dð Þf g
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
v Nð Þ ¼ s Nð Þ; s N þ dð Þ; s N þ 2 dð Þ; . . . ; s N þ D 1ð Þ  dð Þf g
where N ¼ 1024 D 1ð Þ  d
ð1Þ
The Euclidean distance matrix (DMNxN ) for the 15-




v ið Þ  v jð Þ½ 1=2 ð2Þ
The Euclidean distance matrix (DMNxN ) was then nor-








NðN  1Þ=2 ð3Þ
The recurrence map (RM) was then constructed from
DMnormNxN such that the pixel p i; jð Þ was ON if DMnormNxN ≤R
and OFF if DMnormNxN > R , where the threshold was
R ¼ 60 [35]. In the RM, the pixels that were ON were
defined as recurrent (Re) if they share local neighbor-
hoods in higher dimensional space. Therefore, the per-
centage of the plot occupied by Re points was defined as%Rec and the percentage of Re forming lines parallel to
diagonal was defined as %Det. Lines were constituted by





where L was the number of points forming lines.
For each subject, the first-order regression line was
computed from nine data points for %Rec and %Det
during fatiguing contractions of the bilateral MG. The
rate of change in %Rec and %Det was defined as the
slope of the regression line and the initial value as the
intercept of the regression line.
Results
The regression lines capturing the variations in %Rec
and %Det of the surface EMG during 9 s of fatiguing
contractions of the paretic (affected limb) and non-
paretic (unaffected limb) MG muscle before (baseline)
FES-assisted gait training are shown in Figure 3 for all
the subjects (N = 12). The rate of change (slope in
%/second) of %Rec and %Det for the paretic MG
with their 95% confidence interval (CI) were −0.411 (CI =
−0.614 to −0.208) and −1.449 (CI = −1.978 to −0.92),
respectively. In comparison, the rate of change (%/second)
of %Rec and %Det of surface EMG for the non-paretic MG
were 0.193 (CI = 0.072–0.313) and 1.149 (CI = 0.724–
1.573), respectively. Therefore, %Rec and %Det decreased
over 9 s of fatiguing contractions for the paretic MG while
it increased for the non-paretic MG, for all the subjects
pooled together (N = 12). The initial values (intercept in %)
of %Rec and %Det were 5.978 (CI = 4.836–7.12) and 60.829
(CI = 57.852–63.806), respectively, for the paretic MG
while 1.064 (CI = 0.387–1.741) and 41.442 (CI = 39.052–
43.829), respectively, for the non-paretic MG. Therefore,
there was a significant difference in the initial values of %
Rec and %Det for all the subjects pooled together (N = 12),
which were lower for the non-paretic MG than the paretic
MG.
The subjects were randomly divided into two
groups of six subjects each—EMG-triggered (N = 6)
and switch-triggered (N = 6). The changes in the
slope and intercept of the regression line capturing
the variations in %Rec and %Det of the surface EMG
during 9 s of fatiguing contractions of the paretic
(affected limb) and non-paretic (unaffected limb) be-
fore (baseline) and after (post-intervention) FES-
assisted gait training are tabulated in Additional file 1:
Table S2 for each group. The data showed significant
changes in the slope and intercept of the regression line
for both the RQA parameters—%Rec and %Det of the
paretic MG for the EMG-trigger group while the switch-
trigger group showed no significant changes post-
a) b)
)d)c
Figure 3 The pre-intervention (baseline) variations in %Rec and %Det of the surface EMG during 9 s of fatiguing contractions of the
paretic and non-paretic MG muscle for all the subjects pooled together (N = 12). The linear regression line with 95% CI is also shown. (a)
Variation in %Rec for paretic MG, (b) variation in %Rec for non-paretic MG, (c) variation in %Det for paretic MG, (d) variation in %Det for
non-paretic MG.
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ring fatiguing contractions increased from −0.059 (CI =
−0.088 to −0.031) to −0.008(CI = −0.017 to −0.0006) while
that for %Det increased from −1.625 (CI = −2.371 to −0.88)
to −0.4426 (CI = −0.913 to −0.028) for the EMG-trigger
group. Also, the initial value of %Rec decreased from 7.727
(CI = 6.139–9.315) to 2.302 (CI = 1.807 to −2.797)
while that for %Det decreased from 64.164 (CI =
59.968–68.359) to 49.901(CI = 47.252–52.55) for the
EMG-trigger group. The corresponding values for the
switch-trigger group remained statistically unchanged
post-intervention.
Discussion
RQA has been shown to be promising for detecting neuro-
physiological changes in the muscle due to fatigue or other
factors [35]. Farina et al. [35] showed that both the para-
meters—%Rec and %Det—were influenced by the conduc-
tion velocity and synchronization of the motor units of the
muscle and therefore sensitive to the muscle properties.
They also showed that %Det was highly correlated with the
spectral variables and to some extent %Rec as well, and
moreover both the %Det and %Rec were more sensitive to
muscle fatigue than the spectral variables. The mean spec-
tral frequency (MNF) and %Det were highly correlated with
a negative correlation coefficient close to −1.In this study, the parameters from RQA captured the
differences in the muscle properties between paretic and
non-paretic MG muscle (Figure 3) as well as the changes
affected by NMES-assisted gait training interventions—
EMG-triggered versus switch-triggered (Additional file
1: Table S2). From the baseline data, it was found that
the parameters—%Rec and %Det—had a higher initial
value for the paretic MG than the non-paretic MG. A
higher value for %Det indicated a lower MNF for
the paretic MG when compared to the non-paretic
MG. Moreover, the rate of change of %Rec and
%Det during fatiguing contraction was negative for
the paretic MG and positive for the non-paretic MG.
A positive rate of change in %Det indicated a de-
crease in MNF during fatiguing contractions which
is normal [38]; however, a negative rate of change
indicated an increase in MNF which may be patho-
logical for the paretic MG. Moreover, the rate of
change in %Rec and %Det during the fatiguing con-
tractions of the paretic MG increased after NMES-
assisted gait training for the EMG-trigger group.
Felici et al. [39] have shown a higher rate of change
in %Det in weight lifters when compared to the con-
trol group during sustained isometric contractions. A
significant increase in the rate of change in %Det during
fatiguing contractions may indicate exercise-effect on
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NMES-assisted gait training. Therefore, we found
that our short-duration EMG-triggered FES-assisted
gait therapy improved neurophysiological properties
of the muscle and a more intensive treatment with
duration beyond 2 weeks might have shown add-
itional benefits [40-43].
However, lack of accessible rehabilitation facilities and
high cost of rehabilitation at the well-equipped clinics
are current challenges in India which usually lead to
high-dropout of individuals from rehabilitation therapy
following stroke. Such de-conditioned chronic stroke
survivor will need to recondition themselves with a
gradual increase in the intensity (number of hours per
day) and frequency (number of days per week) over the
duration of the FES-assisted gait therapy. In fact, about
20% of stroke survivors suffer muscle atrophy which
underlie worsening metabolic fitness in the chronic
phase of stroke including gross muscular atrophy,
altered muscle molecular phenotype, increased intra-
muscular area fat, elevated tissue inflammatory markers,
and diminished peripheral blood flow dynamics [44].
EMG-triggered FES-assisted gait training may alleviate
these debilitating conditions where increased intensity
and frequency of rehabilitation may help [40]. In fact re-
cent studies in India on therapeutic benefits of FES-
assisted gait training in conjunction with conventional
physiotherapy have shown the additive effects of FES on
reducing spasticity, improving dorsiflexor strength, im-
proving walking ability, and improving metabolic fitness
[41,42]. However, stroke presents with heterogeneous
patient-specific impairments in motor, sensory, tone, vis-
ual, perceptual, cognition, aphasia, apraxia, coordination,
and equilibrium. Therefore, the functional limitations
following stroke are varied, including gait dysfunction,
fall risk, limited activities of daily living, difficulties in
swallowing, reduced upper extremity function, altered
communication, besides others. Based on the residual
function of a stroke survivor, the number of muscles that
can serve as EMG command source [31], the number of
muscles that need FES assistance, intensity, frequency,
and duration of the EMG-triggered FES-assisted gait
training need to be decided. The ability of a stroke sur-
vivor to undergo FES-assisted gait therapy also depends
on their cardiovascular and neuromuscular capacity
besides psychological factors such as motivation. Also,
the FES-assisted gait training should be started as soon
as the patient becomes clinically stable since early inter-
vention has shown better functional outcomes, survival
rates, and reduced length of required therapy [43].
Therefore, we are currently investigating a home-based
rehabilitation model where stroke survivors can use a
low-cost EMG-triggered FES device daily. However,
the efficacy of such home-based models in affectingtherapeutic benefits needs to be validated with neuro-
physiological testing with advanced computational tools
like RQA where parameters like %Rec and %Det can
non-invasively monitor changes in muscle properties
due to NMES-assisted gait training during rehabilitation.
Conclusion
The overarching goal of NMES-assisted gait training is
to facilitate long-term therapeutic changes in muscle
properties. However, a sensitive biomarker is needed to
capture these neurophysiological changes during motor
rehabilitation. In this study, the parameters derived from
RQA captured the significant changes in muscle proper-
ties brought by EMG-triggered NMES-assisted gait
training when compared to switch-triggered NMES-
assisted gait training. The subjects were forced to vol-
itionally activate the paretic MG muscle to generate the
EMG-command signal during EMG-triggered NMES-
assisted gait training which exercised the paretic MG
muscle during a functional task. Therefore, EMG-
triggered NMES-assisted gait training could be more ef-
fective in providing long-term therapeutic benefit in
muscle function than switch-triggered NMES-assisted
gait training. This study also provided an understanding
of RQA parameters—%Rec and %Det, computed from
surface EMG of the paretic and non-paretic muscles
during fatiguing contractions.
Additional file
Additional file 1: Table S2. The changes in the slope and intercept of
the regression line for the parameters—%Det and %Rec during fatiguing
contractions of paretic (affected) and non-paretic (unaffected) MG muscle
before (baseline) and after (post-intervention) FES-assisted gait training,
for the two groups—EMG-triggered and switch-triggered, of six subjects
each. The table shows the Mean and 95% CI of the data. Significant
differences between the baseline and post-intervention values are
shaded.
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